CIC Behavioral Economics in Children With Spina Bifida

Sponsor
Duke University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05562713
Collaborator
(none)
80
2
3
17.5
40
2.3

Study Details

Study Description

Brief Summary

The purpose of the study is to develop a comprehensive program to increase early initiation of self-catheterization in children with Spina Bifida.

This will be a prospective open label randomized control trial. Patients and caregivers/guardians in the intervention arm will be enrolled in a comprehensive program that utilizes behavioral economic theory to incentivize initiation of independent CIC. The study population will be patients aged 6 to 12 years old with diagnosis of spina bifida, including meningocele and myelomeningocele, as defined by International Classification of Diseases, 10th revision (ICD10).

This study will look at behavioral interventions. There are no additional physical risks to participation in the study. Patient demographics will be reported using descriptive statistics. Study team will use Kaplan-Meier curves to demonstrate and compare the probability of achieving independent CIC over time between the study arms.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Present Bias without Loss Aversion
  • Behavioral: Present Bias with Loss Aversion
N/A

Detailed Description

There are three study arms to which patients will be randomized in block randomization fashion with goal recruitment totaling 45 patients. Randomization will begin with Arm 1 and Arm 2 in a 1:1 ratio for the first 20 patients, 10 patients per arm. If accrual is reasonably brisk, we will expand our recruitment to Arm 3 which will then be conducted in a 1:1:3 block randomization for the remaining 25 patients with a total of 15 patients per arm. If accrual is slow and recruitment goal will not be met by expected date, we will continue accrual to Arm 1 and Arm 2 without including Arm 3. Randomization will be performed via NIH clinical trial randomization tool.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Care Provider)
Primary Purpose:
Supportive Care
Official Title:
Leveraging Behavioral Economics to Promote Independent Clean Intermittent Catheterization in Children With Spina Bifida
Anticipated Study Start Date :
Feb 15, 2023
Anticipated Primary Completion Date :
Jun 1, 2024
Anticipated Study Completion Date :
Aug 1, 2024

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control (Arm #1)

CIC will be discussed with caretakers & patients during their appointment and they will be given the instruction sheet to take home. They will not have a follow-up appointment scheduled. Research team will call them to check if the patient is able to perform CIC independently. If they can, a visit will be scheduled for them to demonstrate this in clinic.

Experimental: Present Bias without Loss Aversion (Arm #2)

CIC will be discussed with caretakers & patients during their appointment and they will be given the instruction sheet to take home. Child will receive a prize (~$5-20 in value) for every CIC step completed. They will follow-up in clinic in 3 months (or earlier) to demonstrate their CIC ability. If they can demonstrate this ability, they will receive a large prize (~$30-50 in value)

Behavioral: Present Bias without Loss Aversion
Small prize for each step completed; large prize for independent CIC

Experimental: Present Bias with Loss Aversion (dependent on accrual) (Arm #3)

CIC will be discussed with caretakers & patients during their appointment and they will be given the instruction sheet to take home. Child will pick a prize for every CIC step completed. They will follow-up in clinic in 3 months (or earlier) to demonstrate their CIC ability. All of the prizes that the child picked will be given only if fully-independent CIC is demonstrated.

Behavioral: Present Bias with Loss Aversion
Prizes only if fully independent CIC demonstrated

Outcome Measures

Primary Outcome Measures

  1. Number of participants with independent CIC (Clean Intermittent Catheterization) [3-24 months]

    Upon notification from the caregiver that a child is ready to demonstrate self-CIC, they will come to the Duke Pediatric Urology or Duke Spina Bifida Clinic and meet with study personnel. Participating children will be given supplies and asked to perform CIC in private. Prior to CIC, they will have a bladder scan to measure the pre-CIC bladder volume. After they perform CIC, another bladder scan will be performed to evaluate the post-CIC bladder volume. An adequate post-CIC volume will be defined as less than 20% of the age-appropriate bladder volume.

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of spina bifida, including meningocele and myelomeningocele, as defined by International Classification of Diseases, 10th revision (ICD10). ICD-10 codes will include Q05.0-Q05.9

  • 6-12 years old

  • CIC performed fully by their caregiver

  • Demonstrate manual dexterity to perform CIC (determined by the patient's caregiver and the pediatric urologist in clinic)

  • Communication in English language

Exclusion Criteria:
  • non-English speaking patients

  • less than 6 years old; older than 12 years of age

  • non-spina bifida patients

  • already perform independent or semi-independent CIC

Contacts and Locations

Locations

Site City State Country Postal Code
1 Duke University Hospital Durham North Carolina United States 27701
2 Lenox Baker Children's Hopsital Durham North Carolina United States 27701

Sponsors and Collaborators

  • Duke University

Investigators

  • Principal Investigator: Jonathan Routh, MD, MPH, Duke University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Duke University
ClinicalTrials.gov Identifier:
NCT05562713
Other Study ID Numbers:
  • Pro00111134
First Posted:
Oct 3, 2022
Last Update Posted:
Jan 11, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Duke University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 11, 2023